A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients
PHASE1CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
January 31, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Conditions
Pharmacokinetics of Avycaz in ICU Patients
Interventions
DRUG
Ceftazidime/avibactam
Ceftazadime/avibactam dosing in ICU patients
All Listed Sponsors
lead
Michigan State University
OTHER
NCT02822950 - A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients | Biotech Hunter | Biotech Hunter